tiprankstipranks
Trending News
More News >

CytoDyn engages CRO for Phase II inflammation trial

CytoDyn has engaged Syneos Health as the contract research organization for its upcoming Phase II study exploring leronlimab and its effects on chronic inflammation.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue